Cal. NAACP Resolution: End Use of Psyc Drugs on FosterYouth
AHRP applauds the California chapter of the NAACP for unanimously passing a resolution to end the abusive prescribing of psychotropic drugs for children in foster care!
Potent Narcotic ‘Lollipop’ Becomes Best Seller_WSJ
Off-label prescribing of drugs for unapproved uses puts consumers at high risk of harm–but it is the single most lucrative marketing strategy.
Separating the Facts from the Propaganda_Latest Findings of Depression Study
Today's news report circulated by the media about the negative findings of a much touted, but uncontrolled observational study of depression (STAR*D) promotes the business interests of SSRI antidepressant drug manufacturers.
Infant Mental Health Screen-a Gov-approved Assault
An Orwellian nightmare is being implemented on infants even as the evidence demonstrates that the psychiatry's practice guidelines are corrupted by
industry.
Scientific Fraud: Eric Poehlman / Richard Borison
Medical researchers who commit fraud and research misconduct are caught only when a person of conscience steps up to the plate and blows the whistle. There are no systemic, independent checks and balances to prevent research fraud or abuse of patients.
Sen Schumer asks FDA to place hold on Paxil for kids
Sen Schumer asks FDA to place hold on Paxil for kids Fri, 13 Jun 2003 Senator Charles Schumer held a press conference in New York to announce that he had written to Mark McClellan, FDA Commissioner to investigate the adverse effects of Paxil, the SSRI antidepressant on children and teens,…
VIOXX WITHDRAWAL: FDA TO JOIN AUDIO CONFERENCE ON NOVEMBER 10
VIOXX WITHDRAWAL: FDA TO JOIN AUDIO CONFERENCE ON NOVEMBER 10 Mon, 8 Nov 2004 To hear from FDA Office of New Drugs Acting Director Sandra Kweder, MD, in an interactive discussion of what the withdrawal of the blockbuster drug means for the agencys drug safety programs, the COX-2 inhibitor class…
Acting FDA Head Temporarily Drops NCI Duty – WashPost
Acting FDA Head Temporarily Drops NCI Duty – WashPost Sat, 1 Oct 2005 Who is kidding who? The appointment of a long time Bush friend, Dr. Andrew Eschenbach, head of the National Cancer Institue, as acting commissioner of the Food and Drug Adminsitration reeks of conflicts of interest–not just one…
Federal Court (Illinois) Rejects FDA-Daniel Troy Preemption Argument
Federal Court (Illinois) Rejects FDA-Daniel Troy Preemption Argument Fri, 11 Nov 2005 In yet another federal case (Zikis v Pfizer) involving the company’s failure to warn physicians and the public about the increased risk of suicide effects for pediatric patients prescribed Zoloft, the court rejected Pfizer’s argument that it didn’t need to war…
40 Psychiatrists Lobby FDA to Legitimize Drug Restraints for Aggression
40 Psychiatrists Lobby FDA to Legitimize Drug Restraints for Aggression Mon, 21 Mar 2005 At first glance, a Newsday article–Hot Under the Collar?– might appear as a hilarious parody of bio-psychiatry. It is not. “Recently, 40 scientists met with two FDA officials to make a case for testing treatments specifically…
FDA Scientist Won’t Present New Pain Drug Data – FDA to Create Independent Drug Safety Board
FDA Scientist Won’t Present New Pain Drug Data – FDA to Create Independent Drug Safety Board Tue, 15 Feb 2005 A culture of intimidation prevents FDA safety officers from disclosing important safety information about widely marketed drugs. Reuters reports: “Criticism of how the FDA monitors the after-market safety of drugs…
Conflicts of Interest Taint UK Gov panel investigating SSRI
Conflicts of Interest Taint UK Gov panel investigating SSRI Wed, 19 Mar 2003 An article from the UK Guardian sheds light on how the credibility of an expert investigative government appointed committee is corrupted by financial conflicts of interest. Mounting complaints from patients and the UK watchdog organization, Social Audit,…